18 , 19 The presence and degree of sensitization against marker allergens early on in life (ie, at 4 years of age) serve as highly significant prediction markers for manifest disease later in life (ie, at 8 and 16 years of age) 18 and pave the way for preventive interventions such as those based on virus‐like nanoparticles (VNP).
← all excerpts
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model.
1
—
—